Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single Arm Phase II Clinical Trial

BACKGROUND: Cutaneous squamous cell carcinoma (CSCC) is a very common malignancy. Most patients present with localized disease. Recurrent and metastatic disease is rare, and there is no standard therapy for these patients. These tumors frequently overexpress the epidermal growth factor receptor (EGF...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Gold, Kathryn A., Kies, Merrill S., William, William N., Johnson, Faye M., Lee, J. Jack, Glisson, Bonnie S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935588/
https://ncbi.nlm.nih.gov/pubmed/29579331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31346
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky